Stouge, Anders https://orcid.org/0000-0001-8396-462X
Nielsen-Kudsk, Anders Hammer
Vaeggemose, Michael
Tankisi, Hatice
Bruun, Jens Meldgaard
Andersen, Henning
Funding for this research was provided by:
Aarhus University Hospital
Article History
Received: 28 December 2025
Accepted: 24 June 2026
First Online: 3 July 2026
Declarations
:
: Ethical approval was obtained from the Danish Research Ethics Committees (1–10-72–385-21). The study was conducted in accordance with the Declaration of Helsinki, and was registered at ClinicalTrials.gov (NCT05685927; Registration Date 2023–01-17).
: MV is employed by GE HealthCare but reports no conflicts of interest related to this work. JMB serves on speaker bureaus for Merck, Boehringer Ingelheim, and Novo Nordisk, and has received research support from the Novo Nordisk Foundation; however, none of these relationships are related to the current study. All authors declare no conflicts of interest or relationships that could be perceived to influence the design, conduct, or reporting of this work.
: Authors’ relationships and activities: MV is employed by GE HealthCare but reports no conflicts of interest related to this work. JMB serves on speaker bureaus for Merck, Boehringer Ingelheim, and Novo Nordisk, and has received research support from the Novo Nordisk Foundation; however, none of these relationships are related to the current study. All authors declare no conflicts of interest or relationships that could be perceived to influence the design, conduct, or reporting of this work. Funding: This work was supported by Fonden for Neurologisk Forskning (A3906), Fonden til Lægevidenskabens Fremme, A.P. Møller Fonden (L-2022–00076), and Helga og Peter Kornings Fond (DC274023/JNN). The funders had no role in the design of the study, data collection, analysis, interpretation of results, writing of the manuscript, or the decision to submit it for publication.